Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.01
+0.01 (0.21%)
Sep 14, 2026, 4:00 PM EDT - Market closed
Aura Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Selling, General & Admin | 17.32 | 6.91 | 5.34 | 5.73 | 5.73 | 5.69 | 5.47 | 6.2 | 5.88 | 5.26 | 4.5 | 5.06 | 5.16 | 5.04 | 4.45 | 4.76 | 4.31 | 4.54 | 3.65 | 2.53 |
Research & Development | 30.75 | 27.96 | 21.9 | 22.18 | 22.88 | 23.34 | 22.33 | 17.04 | 16.88 | 17.05 | 20.28 | 15.43 | 15.12 | 14.41 | 13.16 | 11.29 | 9.51 | 8.28 | 7.98 | 6.37 |
Operating Expenses | 48.07 | 34.87 | 27.24 | 27.91 | 28.61 | 29.04 | 27.81 | 23.23 | 22.76 | 22.31 | 24.78 | 20.49 | 20.28 | 19.44 | 17.61 | 16.06 | 13.82 | 12.81 | 11.63 | 8.9 |
Operating Income | -48.07 | -34.87 | -27.24 | -27.91 | -28.61 | -29.04 | -27.81 | -23.23 | -22.76 | -22.31 | -24.78 | -20.49 | -20.28 | -19.44 | -17.61 | -16.06 | -13.82 | -12.81 | -11.63 | -8.9 |
Interest & Investment Income | 2.31 | 1.19 | 1.54 | 1.82 | 1.68 | 1.59 | 2.03 | 2.26 | 2.45 | 2.69 | 2.61 | 1.98 | 2.01 | 1.99 | 1.06 | 0.48 | 0.29 | 0.03 | 0.01 | 0.01 |
Other Non Operating Income (Expenses) | 0.15 | 0 | 0.15 | -0.01 | -0.04 | -0.02 | -0.04 | -0.03 | -0.03 | -0.03 | -0.03 | -0.01 | -0.03 | -0.01 | 0.31 | -0.33 | 0.06 | -0.04 | -0.01 | 0.05 |
EBT Excluding Unusual Items | -45.61 | -33.67 | -25.54 | -26.1 | -26.97 | -27.47 | -25.81 | -21 | -20.34 | -19.66 | -22.2 | -18.51 | -18.3 | -17.47 | -16.24 | -15.9 | -13.47 | -12.83 | -11.63 | -8.84 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | - | - | - | - | - | 0.21 | - | - | - | -0.32 | - | - | -0.01 | - | - |
Pretax Income | -45.61 | -33.67 | -25.54 | -26.1 | -26.97 | -27.47 | -25.81 | -21 | -20.34 | -19.66 | -21.99 | -18.51 | -18.3 | -17.47 | -16.56 | -15.9 | -13.47 | -12.84 | -11.63 | -8.84 |
Income Tax Expense | 0.03 | 0.01 | 0.02 | 0.03 | 0.05 | 0.02 | 0.02 | 0.04 | - | 0.05 | 0.14 | - | - | - | - | - | - | - | - | - |
Net Income | -45.64 | -33.69 | -25.56 | -26.13 | -27.02 | -27.48 | -25.83 | -21.04 | -20.34 | -19.71 | -22.13 | -18.51 | -18.3 | -17.47 | -16.56 | -15.9 | -13.47 | -12.84 | -11.63 | -8.84 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.32 | 3.67 |
Net Income to Common | -45.64 | -33.69 | -25.56 | -26.13 | -27.02 | -27.48 | -25.83 | -21.04 | -20.34 | -19.71 | -22.13 | -18.51 | -18.3 | -17.47 | -16.56 | -15.9 | -13.47 | -12.84 | -12.95 | -12.51 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 95 | 67 | 67 | 66 | 58 | 50 | 50 | 50 | 50 | 49 | 45 | 38 | 38 | 38 | 32 | 29 | 29 | 29 | 19 | 0 |
Shares Outstanding (Diluted) | 95 | 67 | 67 | 66 | 58 | 50 | 50 | 50 | 50 | 49 | 45 | 38 | 38 | 38 | 32 | 29 | 29 | 29 | 19 | 0 |
Shares Change (YoY) | 63.51% | 34.56% | 34.37% | 32.77% | 17.09% | 1.36% | 11.84% | 30.06% | 30.89% | 30.88% | 39.49% | 30.44% | 29.41% | 29.34% | 65.34% | 6531.26% | 6586.60% | 7195.20% | 4986.58% | 17.18% |
EPS (Basic) | -0.48 | -0.50 | -0.38 | -0.40 | -0.47 | -0.55 | -0.52 | -0.42 | -0.41 | -0.40 | -0.50 | -0.48 | -0.48 | -0.46 | -0.52 | -0.54 | -0.46 | -0.44 | -0.67 | -28.33 |
EPS (Diluted) | -0.48 | -0.50 | -0.38 | -0.40 | -0.47 | -0.55 | -0.52 | -0.42 | -0.41 | -0.40 | -0.50 | -0.48 | -0.48 | -0.46 | -0.52 | -0.54 | -0.46 | -0.44 | -0.67 | -28.33 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -32.52 | -30 | -20.65 | -20.19 | -20.81 | -23.54 | -24.25 | -15.61 | -16.65 | -24.54 | -17.7 | -15.49 | -14.84 | -16.52 | -18.37 | -10.82 | -10.7 | -15.8 | -12.91 | -9.26 |
Free Cash Flow Per Share | -0.34 | -0.45 | -0.31 | -0.31 | -0.36 | -0.47 | -0.49 | -0.31 | -0.34 | -0.50 | -0.40 | -0.41 | -0.39 | -0.44 | -0.57 | -0.37 | -0.37 | -0.54 | -0.67 | -20.98 |
EBITDA | -47.81 | -34.59 | -26.97 | -27.63 | -28.33 | -28.74 | -27.52 | -22.92 | -22.45 | -22.01 | -24.46 | -20.15 | -19.98 | -19.12 | -17.29 | -15.75 | -13.52 | -12.56 | -11.4 | -8.68 |
D&A For EBITDA | 0.26 | 0.27 | 0.27 | 0.28 | 0.29 | 0.29 | 0.29 | 0.31 | 0.31 | 0.31 | 0.32 | 0.34 | 0.3 | 0.33 | 0.32 | 0.3 | 0.3 | 0.26 | 0.23 | 0.22 |
EBIT | -48.07 | -34.87 | -27.24 | -27.91 | -28.61 | -29.04 | -27.81 | -23.23 | -22.76 | -22.31 | -24.78 | -20.49 | -20.28 | -19.44 | -17.61 | -16.06 | -13.82 | -12.81 | -11.63 | -8.9 |